Therapeutic Evaluation of Low-dose IL-2-based Immunomodulatory Approach in Patients With Early AD
Clinical trial NCT05468073 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05468073
- Sponsor
- Centre Hospitalier St Anne
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-11
- Primary completion
- 2028-06-08
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.